These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24138426)

  • 1. Role of the renin-angiotensin system on abdominal aortic aneurysms.
    Malekzadeh S; Fraga-Silva RA; Trachet B; Montecucco F; Mach F; Stergiopulos N
    Eur J Clin Invest; 2013 Dec; 43(12):1328-38. PubMed ID: 24138426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms.
    Silverberg D; Younis A; Savion N; Harari G; Yakubovitch D; Sheick Yousif B; Halak M; Grossman E; Schneiderman J
    J Am Soc Hypertens; 2014 Aug; 8(8):571-7. PubMed ID: 24913570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
    Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications.
    Moltzer E; Essers J; van Esch JH; Roos-Hesselink JW; Danser AH
    Pharmacol Ther; 2011 Jul; 131(1):50-60. PubMed ID: 21504760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
    Xu B; Xuan H; Iida Y; Miyata M; Dalman RL
    Curr Drug Targets; 2018; 19(11):1318-1326. PubMed ID: 29359665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin blockade is associated with increased mortality after vascular surgery.
    Railton CJ; Wolpin J; Lam-McCulloch J; Belo SE
    Can J Anaesth; 2010 Aug; 57(8):736-44. PubMed ID: 20524103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
    Schindler C
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):233-48. PubMed ID: 19124424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of abdominal aortic aneurysm.
    Miyake T; Morishita R
    Cardiovasc Res; 2009 Aug; 83(3):436-43. PubMed ID: 19454489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and abdominal aortic aneurysms.
    Daugherty A; Cassis L
    Curr Hypertens Rep; 2004 Dec; 6(6):442-6. PubMed ID: 15527688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms.
    Lu H; Rateri DL; Bruemmer D; Cassis LA; Daugherty A
    Clin Sci (Lond); 2012 Nov; 123(9):531-43. PubMed ID: 22788237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renin-angiotensin system modulation: instructions for use].
    Bellis A; Rozza F; Crispo S; Trimarco B
    G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
    Probstfield JL; O'Brien KD
    Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.